Comparing two versions of the Schedule for Evaluation of Individual Quality of Life in patients with advanced cancer

Acta Oncologica

Volumn 50, Issue 5, 2011, Pages 648-652

  Wettergren, Lena ^a   Lindblad, Åsa Kettis ^b,c   Glimelius, Bengt ^a,b   Ring, Lena ^b,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c Planning Office Quality and Evaluation   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONSULTATION; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; EFFECT SIZE; FEASIBILITY STUDY; FEMALE; HEALTH SURVEY; HUMAN; INTERVIEW; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; SCHEDULE FOR THE EVALUATION OF INDIVIDUAL QUALITY OF LIFE DIRECT WEIGHTING; SCHEDULE FOR THE EVALUATION OF INDIVIDUAL QUALITY OF LIFE DISEASE RELATED; SCORING SYSTEM;

ADULT; AGED; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; HUMANS; INDIVIDUALITY; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; TERMINAL CARE; TIME FACTORS;

EID: 79956136233     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.557088     Document Type: Article

References (24)

1. Sprangers MA. Disregarding clinical trial-based patientreported outcomes is unwarranted: Five advances to substantiate the scientific stringency of quality-of-life measurement Acta Oncol 2010;49:155-63.
2. Brundage MD, Feldman-Stewart D, Tishelman C. How do interventions designed to improve provider-patient communication work? Illustrative applications of a framework for communication Acta Oncol 2010;49:136-43.
3. Velikova G, Keding A, Harley C, Cocks K, Booth L, Smith AB, et al. Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial Eur J Cancer 2010;46:2381-8.
4. Gunnars B, Nygren P, Glimelius B. Assessment of quality of life during chemotherapy Acta Oncol 2001;40:175-84. (Pubitemid 32588119)
5. FDA. Summary minutes from the Oncologic Drugs Advisory Committee 2010-07-20. Available from: http://www. fda.gov/downloads/.../ CommitteesMeetingMaterials/.../ UCM224753.pdf
6. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: Bibliographic study of patient assessed health outcome measures BMJ 2002;324(7351):1417.
7. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements JAMA 1994;272:619-26. (Pubitemid 24255222)
8. Koch T. Life quality vs the 'quality of life ': Assumptions underlying prospective quality of life instruments in health care planning Soc Sci Med 2000;51:419-27. (Pubitemid 30236201)
9. O'Boyle CA, McGee H, Hickey A, O'Malley K, Joyce CRB. Individual quality of life in patients undergoing hip replacement Lancet 1992;339:1088-91.
10. Ruta DA, Garratt AM, Leng M, Russell IT, MacDonald LM. A new approach to the measurement of quality of life. The Patient-Generated Index Med Care 1994;32:1109-26.
11. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: Are available health status surveys adequate? Qual Life Res 1995;4:293-307.
12. Hickey AM, Bury G, O'Boyle CA, Bradley F, O'Kelly FD, Shannon W. A new short form individual quality of life measure (SEIQoL-DW): Application in a cohort of individuals with HIV/AIDS BMJ 1996;313:29-33. (Pubitemid 26229887)
13. Wettergren L, Kettis-Lindblad A, Sprangers M, Ring L. The use, feasibility and psychometric properties of an individualised quality-of-life instrument: A systematic review of the SEIQoL-DW Qual Life Res 2009;18:737-46.
14. Ring L, Lindblad AK, Bendtsen P, Viklund E, Jansson R, Glimelius B. Feasibility and validity of a computer administered version of SEIQoL-DW Qual Life Res 2006;15: 1173-7.
15. Waldron D, O'Boyle CA, Kearney M, Moriarty M, Carney D. Quality-of-life measurement in advanced cancer: Assessing the individual J Clin Oncol 1999;17:3603-11. (Pubitemid 29517933)
16. Wettergren L, Bjorkholm M, Axdorph U, Bowling A, Langius-Eklof A. Individual quality of life in long-term survivors of Hodgkin's lymphoma - a comparative study Qual Life Res 2003;12:545-54. (Pubitemid 37056046)
17. Kettis-Lindblad A, Ring L, Widmark E, Bendtsen P, Glimelius B. Patients ' and doctors ' views of using the schedule for individual quality of life in clinical practice J Support Oncol 2007;5:281-7. (Pubitemid 46995363)
18. Glimelius B, Bergh J, Brandt L, Brorsson B, Gunnars B, Hafstrom L, et al. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types - summary and conclusions Acta Oncol 2001;40:135-54. (Pubitemid 32590833)
19. Fagerlind H, Lindblad AK, Bergstrom I, Nilsson M, Naucler G, Glimelius B, et al. Patient-physician communication during oncology consultations Psychooncology 2008;17: 975-85.
20. Wettergren L, Sprangers M, Bjorkholm M, Langius-Eklof A. Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument Psychooncology 2008;17:338-46. (Pubitemid 351513682)
21. Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T. Estimating clinically signifi cant differences in quality of life outcomes Qual Life Res 2005; 14:285-95. (Pubitemid 40576381)
22. Goldstein LH, Atkins L, Leigh PN. Correlates of Quality of Life in people with motor neuron disease (MND) Amyotroph Lateral Scler Other Motor Neuron Disord 2002;3: 123-9. (Pubitemid 35439538)
23. Kreitler S, Chaitchik S, Rapoport Y, Kreitler H, Algor R. Life satisfaction and health in cancer patients, orthopedic patients and healthy individuals Soc Sci Med 1993;36: 547-56. (Pubitemid 23078778)
24. Prutkin JM, Feinstein AR. Quality-of-life measurements: Origin and pathogenesis Yale J Biol Med 2002;75:79-93. (Pubitemid 34925443)